County
Ada County-City Emergency Services System
Ada County-City Emergency Services System (Boise, ID) carries 54 drugs across 278 dose entries in its current published protocol, effective 2026-02-01.
Drugs and doses54
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2.5 mg | NEB | not captured | not captured | page not captured |
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | not captured | page not captured |
| Hyperkalemia | adult | 10 mg | not captured | not captured | not captured | page not captured |
| Other | adult | 2.5 mg | NEB | not captured | not captured | page not captured |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | not captured | page not captured |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | not captured | page not captured |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | not captured | page not captured |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | not captured | page not captured |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.02 mg/kg | IV/IO | not captured | not captured | page not captured |
| Bradycardia | adult | 1 mg | IV/IO | not captured | not captured | page not captured |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | not captured | page not captured |
| Organophosphate poisoning | adult | 0.02 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Organophosphate poisoning | adult | 0.02 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Organophosphate poisoning | adult | 1 mg | IV/IO | not captured | not captured | page not captured |
| Organophosphate poisoning | adult | 1 mg | IV/IO | not captured | not captured | page not captured |
| Organophosphate poisoning | adult | 1–2 mg | IV/IO/IM | not captured | not captured | page not captured |
| Organophosphate poisoning | adult | 1–2 mg | IV/IO/IM | not captured | not captured | page not captured |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Organophosphate poisoning | peds | 1 mg | IV/IO | not captured | not captured | page not captured |
| Organophosphate poisoning | peds | 1 mg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 0.02 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Other | adult | 0.02 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Other | adult | 1 mg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 1 mg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 1–2 mg | IV/IO/IM | not captured | not captured | page not captured |
| Other | adult | 1–2 mg | IV/IO/IM | not captured | not captured | page not captured |
| Other | peds | 0.02 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Other | peds | 0.02 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Other | peds | 1 mg | IV/IO | not captured | not captured | page not captured |
| Other | peds | 1 mg | IV/IO | not captured | not captured | page not captured |
Beta Blockers
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | null | PO | not captured | not captured | page not captured |
| CHF / pulmonary edema | adult | null | PO | not captured | not captured | page not captured |
| Other | adult | null | PO | not captured | not captured | page not captured |
| Other | adult | null | PO | not captured | not captured | page not captured |
| Other | adult | null | PO | not captured | not captured | page not captured |
| Other | adult | null | PO | not captured | not captured | page not captured |
| Other | adult | null | PO | not captured | not captured | page not captured |
Blood Products
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10–20 mL/kg | IV | not captured | not captured | page not captured |
| Other | adult | 10–30 mL/kg | IV | not captured | not captured | page not captured |
| Other | adult | 20 mL/kg | IV | not captured | not captured | page not captured |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 500–1000 mg | IV/IO | not captured | not captured | page not captured |
| Crush injury | adult | 500–1000 mg | IV | not captured | not captured | page not captured |
| Hyperkalemia | adult | 500–1000 mg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 500–1000 mg | IV/IO | not captured | not captured | page not captured |
Clevidipine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–16 mg | IV | not captured | not captured | page not captured |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 12.5–50 g | IV/IO | not captured | not captured | page not captured |
| Hypoglycemia | adult | 12.5–25 g | IV/IO | not captured | not captured | page not captured |
| Hypoglycemia | adult | 4 mL/kg | IV/IO | not captured | not captured | page not captured |
| Hypoglycemia | adult | 5 mL/kg | IV/IO | not captured | not captured | page not captured |
| Hypoglycemia | peds | 10 mL/kg | IV/IO | not captured | not captured | page not captured |
| Hypoglycemia | peds | 4 mL/kg | IV/IO | not captured | not captured | page not captured |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | not captured | page not captured |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–5 mg | IV | not captured | not captured | page not captured |
| Agitation | adult | 5–10 mg | IM | not captured | not captured | page not captured |
| Procedural sedation | adult | 2–5 mg | IV | not captured | not captured | page not captured |
| Seizure | adult | 0.2 mg/kg | IV/IO | not captured | not captured | page not captured |
| Seizure | adult | 0.5 mg/kg | PR | not captured | not captured | page not captured |
| Seizure | adult | 2–10 mg | IV/IO | not captured | not captured | page not captured |
| Seizure | adult | 5–10 mg | IM/PR | not captured | not captured | page not captured |
| Seizure | peds | 0.2 mg/kg | IV/IO | not captured | not captured | page not captured |
| Seizure | peds | 0.5 mg/kg | PR | not captured | not captured | page not captured |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 10 mg | IV | not captured | not captured | page not captured |
| Atrial fibrillation with RVR | adult | 5–15 mg | IV/IO | not captured | not captured | page not captured |
| SVT | adult | 10 mg | IV | not captured | not captured | page not captured |
| SVT | adult | 5–15 mg | IV/IO | not captured | not captured | page not captured |
| Narrow-complex tachycardia | adult | 10 mg | IV | not captured | not captured | page not captured |
| Narrow-complex tachycardia | adult | 5–15 mg | IV/IO | not captured | not captured | page not captured |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1–2 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Anaphylaxis | adult | 25 mg | PO | not captured | not captured | page not captured |
| Anaphylaxis | adult | 25–50 mg | IV/IO/IM | not captured | not captured | page not captured |
| Anaphylaxis | adult | 25–50 mg | PO | not captured | not captured | page not captured |
| Anaphylaxis | peds | 1–2 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Anaphylaxis | peds | 25 mg | PO | not captured | not captured | page not captured |
| Dystonic reaction | adult | 1 mg/kg | IV/IM | not captured | not captured | page not captured |
| Dystonic reaction | adult | 25–50 mg | IV/IM | not captured | not captured | page not captured |
| Dystonic reaction | peds | 1 mg/kg | IV/IM | not captured | not captured | page not captured |
| Nausea / vomiting | adult | 25–50 mg | IV/IO/IM | not captured | not captured | page not captured |
Dobutamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 2–20 mcg/kg | IV/IO | not captured | not captured | page not captured |
| Hypotension / shock | adult | 2–20 mcg/kg | IV/IO | not captured | not captured | page not captured |
| Hypotension / shock | adult | 2–20 mcg/kg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 2–20 mcg/kg | IV/IO | not captured | not captured | page not captured |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 2–20 mcg/kg | IV/IO | not captured | not captured | page not captured |
| Hypotension / shock | adult | 2–20 mcg/kg | IV/IO | not captured | not captured | page not captured |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 0.625–1.25 mg | IV/IO | not captured | not captured | page not captured |
| Nausea / vomiting | adult | 2.5 mg | IM | not captured | not captured | page not captured |
| Procedural sedation | adult | 1.25–2.5 mg | IV/IO | not captured | not captured | page not captured |
| Procedural sedation | adult | 5–10 mg | IM | not captured | not captured | page not captured |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.15 mg | IM | not captured | not captured | page not captured |
| Anaphylaxis | adult | 0.3 mg | IM | not captured | not captured | page not captured |
| Anaphylaxis | adult | 0.5 mg | IM | not captured | not captured | page not captured |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | not captured | page not captured |
| Anaphylaxis | peds | 0.3 mg | IM | not captured | not captured | page not captured |
| Anaphylaxis | peds | 0.5 mg | IM | not captured | not captured | page not captured |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IM/SQ | not captured | not captured | page not captured |
| Bradycardia | peds | 0.05–1 mcg/kg | IV/IO | not captured | not captured | page not captured |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | not captured | page not captured |
| Croup | adult | 3 mg | NEB | not captured | not captured | page not captured |
| Croup | peds | 3 mg | NEB | not captured | not captured | page not captured |
| Hypotension / shock | adult | 20 mcg | IV/IO | not captured | not captured | page not captured |
| Other | peds | 3 mg | NEB | not captured | not captured | page not captured |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.2–0.4 mg/kg | IV/IO | not captured | not captured | page not captured |
Famotidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.5 mg/kg | IV/IO | not captured | not captured | page not captured |
| Anaphylaxis | adult | 20 mg | IV/IO | not captured | not captured | page not captured |
| Anaphylaxis | adult | 20 mg | PO | not captured | not captured | page not captured |
| Anaphylaxis | adult | 20–40 mg | PO | not captured | not captured | page not captured |
| Anaphylaxis | peds | 0.5 mg/kg | IV/IO | not captured | not captured | page not captured |
| Anaphylaxis | peds | 20 mg | PO | not captured | not captured | page not captured |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | not captured | page not captured |
| Mild to moderate pain | adult | 1–2 mcg/kg | IV/IO/IM/IN | not captured | not captured | page not captured |
| Mild to moderate pain | peds | 1–2 mcg/kg | IV/IO/IM/IN | not captured | not captured | page not captured |
Heparin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | null | IV/IO/SQ | not captured | not captured | page not captured |
| Atrial fibrillation with RVR | adult | null | IV/IO/SQ | not captured | not captured | page not captured |
| Other | adult | null | IV/IO/SQ | not captured | not captured | page not captured |
| Other | adult | null | IV/IO/SQ | not captured | not captured | page not captured |
| Other | adult | null | IV/IO/SQ | not captured | not captured | page not captured |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 0.5 mg | IV/IM | not captured | not captured | page not captured |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | not captured | page not captured |
Insulin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperglycemia / DKA | adult | 0.05–0.1 unit/kg | IV/IO | not captured | not captured | page not captured |
| Hyperglycemia / DKA | adult | 0.05–0.1 unit/kg | IV/IO | not captured | not captured | page not captured |
| Hyperkalemia | adult | 0.05–0.1 unit/kg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 0.05–0.1 unit/kg | IV/IO | not captured | not captured | page not captured |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.5 mg | NEB | not captured | not captured | page not captured |
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | not captured | page not captured |
| Other | adult | 0.5 mg | NEB | not captured | not captured | page not captured |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 mg/kg | IV/IO | not captured | not captured | page not captured |
| Mild to moderate pain | adult | 0.2 mg/kg | IV/IO | not captured | not captured | page not captured |
| Mild to moderate pain | adult | 0.5 mg/kg | IM | not captured | not captured | page not captured |
| Procedural sedation | adult | 1–2 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| RSI induction | adult | 1–2 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| RSI induction | adult | 1–2 mg/kg | IV/IO | not captured | not captured | page not captured |
Levetiracetam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20 mg/kg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 500–2000 mg | IV/IO | not captured | not captured | page not captured |
| Seizure | adult | 20 mg/kg | IV/IO | not captured | not captured | page not captured |
| Seizure | adult | 500–2000 mg | IV/IO | not captured | not captured | page not captured |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1–1.5 mg/kg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 1–1.5 mg/kg | IV/IO | not captured | not captured | page not captured |
| Mild to moderate pain | adult | 20–40 mg | IO | not captured | not captured | page not captured |
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV/IO | not captured | not captured | page not captured |
| Tricyclic overdose | adult | 1–1.5 mg/kg | IV | not captured | not captured | page not captured |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.5–2 mg | IV/IO | not captured | not captured | page not captured |
| Agitation | adult | 2 mg | IM | not captured | not captured | page not captured |
| Other | adult | 0.05 mg/kg | IV/IO | not captured | not captured | page not captured |
| Procedural sedation | adult | 0.05–0.1 mg/kg | IV/IO | not captured | not captured | page not captured |
| Procedural sedation | adult | 0.1 mg/kg | IM | not captured | not captured | page not captured |
| Procedural sedation | adult | 0.5–2 mg | IV/IO | not captured | not captured | page not captured |
| Procedural sedation | adult | 2 mg | IM | not captured | not captured | page not captured |
| Procedural sedation | peds | 0.05–0.1 mg/kg | IV/IO | not captured | not captured | page not captured |
| Procedural sedation | peds | 0.1 mg/kg | IM | not captured | not captured | page not captured |
| Status epilepticus | adult | 0.1 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Status epilepticus | adult | 1–2 mg | IV/IO | not captured | not captured | page not captured |
| Status epilepticus | adult | 1–2 mg | IM | not captured | not captured | page not captured |
| Status epilepticus | peds | 0.1 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | not captured | page not captured |
| Cardiac arrest | adult | 2 g | IV/IO | not captured | not captured | page not captured |
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | not captured | page not captured |
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | not captured | page not captured |
| Wide-complex tachycardia | adult | 2 g | IV/IO | not captured | not captured | page not captured |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | not captured | page not captured |
Mannitol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Head injury / TBI | adult | 1.5–2 g/kg | IV | not captured | not captured | page not captured |
| Head injury / TBI | peds | 0.25–0.5 g/kg | IV | not captured | not captured | page not captured |
| Other | adult | 0.25–0.5 g/kg | IV | not captured | not captured | page not captured |
| Other | adult | 0.25–0.5 g/kg | IV | not captured | not captured | page not captured |
| Other | adult | 0.25–0.5 g/kg | IV | not captured | not captured | page not captured |
| Other | peds | 0.25–0.5 g/kg | IV | not captured | not captured | page not captured |
| Other | peds | 0.25–0.5 g/kg | IV | not captured | not captured | page not captured |
| Other | peds | 0.25–0.5 g/kg | IV | not captured | not captured | page not captured |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1–2 mg/kg | IV | not captured | not captured | page not captured |
| Anaphylaxis | adult | 125 mg | IV/IO/IM | not captured | not captured | page not captured |
| Anaphylaxis | peds | 1–2 mg/kg | IV | not captured | not captured | page not captured |
| Asthma / bronchospasm | adult | 1–2 mg/kg | IV | not captured | not captured | page not captured |
| Asthma / bronchospasm | adult | 125 mg | IV/IO/IM | not captured | not captured | page not captured |
| Asthma / bronchospasm | peds | 1–2 mg/kg | IV | not captured | not captured | page not captured |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 2.5 mg | IN | not captured | not captured | page not captured |
| Other | adult | 0.05–0.1 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Other | adult | 0.2 mg/kg | IN | not captured | not captured | page not captured |
| Other | adult | 2.5 mg | IN | not captured | not captured | page not captured |
| Other | peds | 0.05–0.1 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Other | peds | 0.2 mg/kg | IN | not captured | not captured | page not captured |
| Seizure | adult | 0.1 mg/kg | IV/IO | not captured | not captured | page not captured |
| Seizure | adult | 0.2 mg/kg | IM/IN | not captured | not captured | page not captured |
| Seizure | adult | 5 mg | IN | not captured | not captured | page not captured |
| Seizure | adult | 5 mg | IM | not captured | not captured | page not captured |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | not captured | page not captured |
| Seizure | peds | 0.2 mg/kg | IM/IN | not captured | not captured | page not captured |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.1 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 2 mg | IV/IO | not captured | not captured | page not captured |
| Opioid overdose | adult | 0.1 mg/kg | not captured | not captured | not captured | page not captured |
| Opioid overdose | adult | 2–4 mg | IM/IN | not captured | not captured | page not captured |
| Opioid overdose | adult | 2–8 mg | IM/IN | not captured | not captured | page not captured |
| Opioid overdose | peds | 0.01–0.05 mg/kg | IV/IO | not captured | not captured | page not captured |
| Opioid overdose | peds | 0.1 mg/kg | not captured | not captured | not captured | page not captured |
| Opioid overdose | peds | 2–8 mg | IM/IN | not captured | not captured | page not captured |
Nerve Agent Antidote Kit
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 2.1 mg | IM | not captured | not captured | page not captured |
Nicardipine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5 mg | IV | not captured | not captured | page not captured |
| Other | adult | 5 mg | IV | not captured | not captured | page not captured |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | not captured | page not captured |
| ACS / chest pain | adult | 0.5–1.5 inch | TD | not captured | not captured | page not captured |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | not captured | page not captured |
| CHF / pulmonary edema | adult | 0.8 mg | SL | not captured | not captured | page not captured |
| Other | adult | 0.4 mg | SL | not captured | not captured | page not captured |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 0.15 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Nausea / vomiting | adult | 0.15 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Nausea / vomiting | adult | 4 mg | ODT | not captured | not captured | page not captured |
| Nausea / vomiting | adult | 4 mg | ODT | not captured | not captured | page not captured |
| Nausea / vomiting | adult | 4 mg | IV/IO/IM | not captured | not captured | page not captured |
| Nausea / vomiting | adult | 4 mg | IV/IO/IM | not captured | not captured | page not captured |
| Nausea / vomiting | peds | 0.15 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Nausea / vomiting | peds | 0.15 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15–45 g | PO | not captured | not captured | page not captured |
| Hypoglycemia | adult | 5–45 g | PO | not captured | not captured | page not captured |
| Hypoglycemia | peds | 5–45 g | PO | not captured | not captured | page not captured |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IV/IO | not captured | not captured | page not captured |
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | not captured | page not captured |
Phenylephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 100–180 mcg | IV | not captured | not captured | page not captured |
| Hypotension / shock | adult | 50–200 mcg | not captured | not captured | not captured | page not captured |
| Other | adult | 1 spray | IN | not captured | not captured | page not captured |
| RSI induction | adult | 1–2 spray | IN | not captured | not captured | page not captured |
| RSI induction | adult | 2–4 spray | IN | not captured | not captured | page not captured |
| RSI induction | peds | 1–2 spray | IN | not captured | not captured | page not captured |
Potassium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–1 mEq/kg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 20–60 mEq | IV/IO | not captured | not captured | page not captured |
| Other | peds | 0.5–1 mEq/kg | IV/IO | not captured | not captured | page not captured |
Propofol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 5–50 mcg/kg | IV/IO | not captured | not captured | page not captured |
Proton Pump Inhibitors
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20–40 mg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 20–40 mg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 20–40 mg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 20–40 mg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 60 mg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 60 mg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 60 mg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 60 mg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 80 mg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 80 mg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 80 mg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 80 mg | IV/IO | not captured | not captured | page not captured |
| Trauma / hemorrhage | adult | 20–40 mg | IV/IO | not captured | not captured | page not captured |
| Trauma / hemorrhage | adult | 60 mg | IV/IO | not captured | not captured | page not captured |
| Trauma / hemorrhage | adult | 80 mg | IV/IO | not captured | not captured | page not captured |
Ranitidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 1 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Allergic reaction | adult | 1 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Allergic reaction | adult | 50 mg | IV/IO/IM | not captured | not captured | page not captured |
| Allergic reaction | adult | 50 mg | IV/IO/IM | not captured | not captured | page not captured |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Anaphylaxis | adult | 1 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| Anaphylaxis | adult | 50 mg | IV/IO/IM | not captured | not captured | page not captured |
| Anaphylaxis | peds | 1 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV/IO | not captured | not captured | page not captured |
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | not captured | page not captured |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 1 mEq/kg | IV | not captured | not captured | page not captured |
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 1 mEq/kg | IV/IO | not captured | not captured | page not captured |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | not captured | page not captured |
Sodium Nitroprusside
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.3–5 mcg/kg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 0.3–5 mcg/kg | IV/IO | not captured | not captured | page not captured |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1–2 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| RSI induction | adult | 2 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
| RSI induction | peds | 2 mg/kg | IV/IO/IM | not captured | not captured | page not captured |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1-3 gtts | not captured | not captured | not captured | page not captured |
Thrombolytics-Fibrinolytics
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 1.5 million units | IV | not captured | not captured | page not captured |
| ACS / chest pain | adult | 10 unit | IV | not captured | not captured | page not captured |
| ACS / chest pain | adult | 15 mg | IV | not captured | not captured | page not captured |
| Stroke | adult | 0.9 mg/kg | IV | not captured | not captured | page not captured |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg/kg | IN | not captured | not captured | page not captured |
| Other | adult | 10 mg/kg | NEB | not captured | not captured | page not captured |
| Other | adult | 15 mg/kg | IV/IO | not captured | not captured | page not captured |
| Other | adult | 2 g | IV/IO | not captured | not captured | page not captured |
| Other | adult | 2 g | IV/IO | not captured | not captured | page not captured |
| Other | adult | 500 mg | NEB | not captured | not captured | page not captured |
| Other | peds | 10 mg/kg | IN | not captured | not captured | page not captured |
| Other | peds | 10 mg/kg | NEB | not captured | not captured | page not captured |
| Other | peds | 15 mg/kg | IV/IO | not captured | not captured | page not captured |
Vasopressin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 40 unit | IV/IO | not captured | not captured | page not captured |
| Hypotension / shock | adult | 0.01–0.1 unit | IV/IO | not captured | not captured | page not captured |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg/kg | IV | not captured | not captured | page not captured |
| RSI induction | adult | 0.1 mg/kg | IV | not captured | not captured | page not captured |